StockStory Flags Chemed’s Growth and Margin Record After Rally
The publisher cited slower five-year sales growth and a declining adjusted operating margin while calling Chemed’s valuation fair.
Key takeaways
- Chemed’s sales grew at a 4.1% annualized rate over the past five years, according to StockStory.
- StockStory said Chemed’s adjusted operating margin fell 3.9 percentage points over five years.
StockStory said Chemed’s business quality fell short of its standards, despite the stock’s 26.2% rise over six months to $493.23, as reported in the article. The publisher said the shares outperformed the S&P 500 by 11.9% over that period.
The publisher pointed to sales growth of 4.1% annually over five years and a 3.9 percentage-point decline in adjusted operating margin. Chemed’s adjusted operating margin was 13.5% for the trailing 12 months, according to StockStory.
StockStory described the shares’ valuation of 19.4 times forward earnings as fair, but said it had little confidence in the company. As of Friday afternoon, Chemed shares traded at $499.24, up 0.2% since the previous close.
This article was produced with the help of AI technology. Source: Yahoo Finance
